This study presents the first comprehensive whole-genome sequencing (WGS) characterization of adolescent-onset gout in a Chinese cohort. Researchers identified four novel genetic loci—most notably RCOR1—that drive the disease not by increasing uric acid levels, but by heightening the immune system's inflammatory response to urate crystals.
What Problem Does This Paper Address?
Gout is a painful inflammatory arthritis caused by the deposition of monosodium urate (MSU) crystals in joints. While typically seen in older adults, its prevalence is rising among adolescents and young adults. Adolescent-onset gout is particularly aggressive, characterized by higher urate levels, faster development of joint damage (tophi), and a much stronger family history (up to 43.8%) compared to adult-onset cases.
Despite this strong genetic signal, most existing research focuses on adults. Previous studies largely identified variants in urate transporter genes like ABCG2, which affect how the body excretes uric acid. However, these don't fully explain why some adolescents develop severe inflammation while others with similar urate levels do not. There was a critical gap in understanding the specific "inflammatory landscape" of early-onset gout.
Methods
The researchers employed a multi-stage genomic approach:
Whole Genome Sequencing (WGS): Unlike standard array-based GWAS that look at common variants, WGS allowed the team to capture the full spectrum of genetic variation, including common and uncommon single nucleotide variations (SNVs) and small insertions/deletions (indels).
Discovery & Replication: They sequenced a discovery cohort of 905 individuals (onset age 12-19) and replicated findings in an early-onset cohort of 2,834 individuals (onset age ≤ 30).
Advanced Association Testing: They used SKAT (Sequence Kernel Association Test) to identify genes driven by low-frequency variants and TWAS (Transcriptome-Wide Association Study) to link genetic variants to gene expression patterns.
Functional Validation: To move beyond correlation, they performed RT-qPCR and RNA-seq on human blood samples and conducted knockdown experiments in THP-1 macrophage cells to observe how candidate genes affect the secretion of IL-1β, the primary "flare" cytokine in gout.
Datasets
Primary Cohort: 905 Chinese males (280 with adolescent-onset gout, 191 with hyperuricemia, and 434 healthy controls).
Replication Cohort: 2,834 Chinese males (824 early-onset gout, 926 hyperuricemia, and 1,084 healthy controls).
Reference Panels: Data were compared against global benchmarks including dbSNP, ExAC, gnomAD, and the 1000 Genomes Project.
Expression Data: GTEx v.8 was used for the TWAS analysis across gout-relevant tissues.
Key Insights and Ideas
Inflammation vs. Excretion: The most significant "aha moment" was the discovery that early-onset gout is driven by genes regulating the immune response to crystals, rather than just genes regulating urate levels.
The Role of RCOR1: The gene RCOR1 (REST corepressor 1) emerged as a major player. Interestingly, variants in RCOR1 did not correlate with serum urate concentrations. Instead, they were linked to higher mRNA expression in leukocytes, making the immune system "primed" to overreact to MSU crystals.
Low-Frequency Variants Matter: The study found that associations at well-known loci like ABCG2 and SLC22A12 were actually driven by low-frequency variants in this younger population, highlighting the necessity of WGS over traditional genotyping arrays for early-onset diseases.
Potential Drug Targets: By showing that knocking down RCOR1 significantly reduces IL-1β production, the authors identified a potential pathway for new therapeutic interventions specifically for gouty flares.
Key Results
Four Novel Loci: The meta-analysis identified four novel common risk loci with genome-wide significance ($P < 5.0 \times 10^{-8}$): VPRBP, NKILA-MIR4532, RCOR1, and FSTL5-MIR4454.
Harmful Exome Variants: Eight uncommon SNVs and three indels in the exome (including genes like LIPH and PKHD1) were predicted to be deleterious and were found exclusively in gout cases.
Functional Impact of RCOR1: Carriers of the RCOR1 risk allele (AA) showed significantly higher mRNA levels in their blood compared to non-carriers. In lab cultures, reducing RCOR1 expression led to a dramatic decrease in both pro-IL-1β and secreted IL-1β after exposure to MSU crystals.
Limitations and Future Work
The authors acknowledge several limitations:
Sample Size for Rare Variants: While large for an adolescent cohort, the study still had limited power to discover extremely rare variants due to the low overall prevalence of the condition in this age group.
Population Specificity: The study was conducted entirely on a Chinese male cohort. Because gout is rare in pre-menopausal females and genetic backgrounds vary, these results need validation in female and non-Asian populations.
Mechanism Depth: While RCOR1 was validated, the specific regulatory mechanisms for the other three novel loci (VPRBP, NKILA, FSTL5) remain to be elucidated in future studies.
Summary updated
Abstract
Summary Background Gout is a polygenetic inflammatory disease. Although hundreds of genetic variants associated with gout and serum urate levels have been identified in studies of adults, the pathogenesis of adolescent-onset gout remains unclear. To better characterize the genetic landscape of adolescent-onset gout, a whole genome sequencing study was done in a large Chinese adolescent-onset gout cohort. Methods We conducted whole genome sequencing in a discovery adolescent-onset gout cohort of 905 individuals (gout onset 12-19 years) to discover common SNVs, uncommon SNVs, and indels associated with gout. Candidate common SNVs were replicated in an early-onset gout cohort of 2834 individuals (gout onset ≤ 30 years old). Loci associated with early-onset gout ( P < 5.0 × 10 −8 ) were identified after meta-analysis with the discovery and replication cohorts. Transcriptome and epigenomic analyses, RT-qPCR and RNA-seq in human peripheral blood leukocytes, and knock-down experiments in human THP-1 macrophage cells investigated regulation and functions of candidate gene RCOR1 . Findings In addition to ABCG2 , a urate transporter previously linked to pediatric-onset and early-onset gout, we identified four novel loci: VPRBP (rs868933181, P meta = 6.27 × 10 −9 ; OR meta = 1.66), NKILA-MIR4532 (rs72626599, P meta = 6.48 × 10 −9 ; OR meta = 1.58), RCOR1 (rs12887440, P meta = 3.37 × 10 −8 ; OR meta = 1.48), and FSTL5 - MIR4454 (rs35213808, P meta = 4.02 × 10 −8 ; OR meta = 1.49). Additionally, we found association at ABCG2 and SLC22A12 that was driven by low frequency SNVs. Furthermore, eight uncommon SNVs and three indels in the exome were predicted to be harmful. SNVs in RCOR1 were linked to heightened blood leukocyte mRNA levels. THP-1 macrophage culture studies revealed the potential of decreased RCOR1 to suppress gouty inflammation. Interpretation Performing the first comprehensive characterization of adolescent-onset gout genomes identified risk loci of early-onset gout. Loci mediate inflammatory responsiveness to crystals that could mediate gouty arthritis. This study will contribute to risk prediction and therapeutic interventions to prevent adolescent-onset gout. Funding The National Natural Science Foundation of China and the National Key R&D Program of China. Research in context Evidence before this study Gout is a polygenic disease and can present in adolescents and young adults. We searched PubMed for studies published as of Dec 31, 2021, without starting date or language restrictions and with the terms “adolescent-onset gout”, “early-onset gout”, “whole genome sequencing”, and “GWAS”, and no reports were found. Although GWAS have identified hundreds of genetic variants associated with gout and serum urate levels, they are all identified in adults (mean age 37.6-76.4 years old). The mechanism of early-onset gout is still unclear. The variants previously associated with early-onset gout are only in ABCG2 . Due to the lack of large-scale genetic studies of the adolescent gout population, the mechanism of the early-onset gout is unknown. Added value of this study To the best of our knowledge, this is the first report of the comprehensive characterization of adolescent gout genomes. We identified common and uncommon risk loci of early-onset gout, most of which implicated in inflammation response, including RCOR1 . SNVs in candidate risk gene RCOR1 displayed expression regulation function. Knockdown of RCOR1 decreased IL-1β levels in THP-1 cells after MSU treatment. These immune-related genetic variants leading to heightened inflammatory responses to monosodium urate (MSU) crystals may contribute to early onset of gout in adolescents. Implications of all the available evidence This is the first report of the genetic landscape of adolescent-onset gout and increases our knowledge of the biological mechanisms underlying early-onset gout. The immune-related loci associated with early-onset gout discovered in this study are potential drug targets. Reducing inflammatory MSU crystal inflammatory responses to MSU crystals is a central objective in the prevention and treatment of adolescent-onset gout.
BibTeX
@misc{ji2023novel,
author = {Aichang Ji and Yang Sui and Xiaomei Xue and Xiaopeng Ji and Yongyong Shi and Robert Terkeltaub and Nicola Dalbeth and Riku Takei and Fei Yan and Mingshu Sun and Maichao Li and Jie Lü and Lingling Cui and Zhen Liu and Can Wang and Xinde Li and Lin Han and Zhanjie Fang and Wenyan Sun and Yue Liang and Yuwei He and Guangmin Zheng and Xuefeng Wang and Jiayi Wang and Hui Zhang and Lei Pang and Han Qi and Yushuang Li and Cheng Zan and Zhiqiang Li and Jingfa Xiao and Changqing Zeng and Tony R. Merriman and Hongzhu Qu and Xiangdong Fang and Changgui Li},
title = {{Novel genetic loci in adolescent-onset gout derived from whole genome sequencing of a Chinese cohort}},
year = {2023},
doi = {10.1101/2023.04.18.23288731},
howpublished = {medRxiv},
}